anastrozole has been researched along with Condition, Preneoplastic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We assessed whether the addition of a lower dose of tamoxifen influenced anastrozole bioavailability and favorably modulated biomarkers of bone fracture, breast cancer, cardiovascular disease, and endometrial cancer risk." | 2.74 | Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia. ( Bonanni, B; Cassano, E; Cazzaniga, M; Decensi, A; Gandini, S; Guerrieri-Gonzaga, A; Johansson, H; Lien, EA; Luini, A; Macis, D; Oldani, S; Pelosi, G; Serrano, D, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonanni, B | 1 |
| Serrano, D | 1 |
| Gandini, S | 1 |
| Guerrieri-Gonzaga, A | 1 |
| Johansson, H | 1 |
| Macis, D | 1 |
| Cazzaniga, M | 1 |
| Luini, A | 1 |
| Cassano, E | 1 |
| Oldani, S | 1 |
| Lien, EA | 1 |
| Pelosi, G | 1 |
| Decensi, A | 1 |
1 trial available for anastrozole and Condition, Preneoplastic
| Article | Year |
|---|---|
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasia.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Cytochrom | 2009 |